NLM Logo

ocaratuzumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
ocaratuzumab
Unique ID
C550337
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C550337
Entry Term(s)
AME 133
AME-133
AME-133V
AME133
LY 2469298
LY-2469298
LY2469298
Registry Number
NTY9893GD0
Previous Indexing
*ANTIBODIES, MONOCLONAL (2010-2015)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
5
Note
an anti-CD20 antibody for treatment of cancer in phase I/II clinical trials (2010)
Source
Semin Hematol 2010 Apr;47(2):199-210
Date of Entry
2010/06/27
Revision Date
2019/10/31
ocaratuzumab Preferred
LY 2469298 Narrower
AME 133 Narrower
page delivered in 0.005s